LESLIE REDDEN: Open Payments
NPI 1952800724 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 44 payments from 14 companies in 2025. Trend: 2023 $24 · 2024 $31 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 12 | $362 |
| Merck Sharp & Dohme LLC | 6 | $178 |
| PFIZER INC. | 7 | $148 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| EMD Serono, Inc. | 2 | $67 |
| Theratechnologies Inc. | 2 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $30 |
Products named: DOVATO, PIFELTRO, TRUMENBA, CABENUVA, EGRIFTA, CAPLYTA, UZEDY, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
